Why is ANG Lifesciences falling/rising?

As of 08-Oct, ANG Lifesciences India Ltd is experiencing a decline in its stock price, currently at Rs 32.94, which reflects a decrease of Rs 1.24 or 3.63%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a 6.95% drop over the past week. Despite opening with a gain of 4.42% today and reaching an intraday high of Rs 35.79, it has also touched a low of Rs 32.51. The stock's performance over the last year shows a significant decline of 33.75%, and it has consistently underperformed against the benchmark indices, indicating weak long-term fundamentals, as evidenced by a -153.70% CAGR growth in operating profits over the last five years and negative results for the last 13 quarters.
In the broader market context, while the Sensex has gained 0.98% over the past week, ANG Lifesciences has seen a notable decline, highlighting its underperformance relative to the market. The stock's liquidity is sufficient for trading, but the high debt-to-EBITDA ratio of 5.83 times and the fact that 44.88% of promoter shares are pledged contribute to the stock's risk profile, further pressuring its price. The negative operating profits and low ability to service debt indicate ongoing financial struggles, which are likely influencing investor sentiment and leading to the stock's recent downward trend.